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Background: Pulmonary regurgitation appears to be well tolerated early after
repair of tetralogy of Fallot; however, it may result in progressive right ven-
tricular dilatation and dysfunction necessitating eventual valve replacement.
Our objective was to review our experience with late pulmonary valve
replacement after complete repair of tetralogy of Fallot.
Methods and results: A total of 42 patients (16 female and 26 male) were oper-
ated on between July 1, 1974, and January 1, 1998. Mean age was 22 years
(range 2-65 years). The mean interval between tetralogy repair and pulmonary
valve replacement was 10.8 years (range 1.6 months–33 years). Mean follow-
up was 7.8 ± 6.0 years (maximum 23 years). Indications for pulmonary valve
replacement included decreased exercise tolerance in 58%, right heart failure in
21%, arrhythmia in 14%, syncope in 10%, and progressive isolated right ven-
tricular dilatation in 7%. Heterograft prostheses were used in 33 patients and
homografts in 9. Five patients underwent isolated pulmonary valve replace-
ment; concomitant procedures performed in 37 patients included tricuspid valve
repair/replacement (n = 18), residual ventricular septal defect repair (n = 12),
atrial septal defect closure (n = 4), pulmonary artery patch angioplasty (n = 17),
and right ventricular outflow tract enlargement (n = 13). One patient died early
(2%) of multiorgan failure. There were 6 late deaths, 3 of which were cardiac
related. Survival was 95.1% ± 3.4% and 76.4% ± 8.9% at 5 and 10 years,
respectively. Functional class of patients was improved significantly; preopera-
tively, 76% of patients were in New York Heart Association class III-IV, and
after pulmonary valve replacement, 97% of surviving patients were in class I-II
(P = .0001). Moderate to severe reduction in right ventricular function was
noted on preoperative echocardiography in 59% and on late echocardiography
in 18% (P = .03). Of the 5 patients who had supraventricular arrhythmias before
pulmonary valve replacement, 1 had postoperative recurrence and the arrhyth-
mia is controlled with antiarrhythmic therapy; the other 4 are in normal sinus
rhythm at late follow-up. Eight patients subsequently underwent pulmonary
valve re-replacement without early mortality at a mean interval of 9.0 ± 4.2
years (range 3.8-16.8 years). Freedom from pulmonary valve re-replacement
was 93.1% ± 4.7% and 69.8% ± 10.7% at 5 and 10 years, respectively. The only
significant risk factor for re-replacement was young age at the time of the ini-
tial pulmonary valve replacement (P = .023).
Conclusion: Late pulmonary valve replacement after tetralogy repair signifi-
cantly improves right ventricular function, functional class, and atrial arrhyth-
mias, and it can be performed with low mortality. Subsequent re-replacement
may be necessary to maintain functional improvement.  (J Thorac Cardiovasc
Surg 2001;121:344-51)
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R epair of tetralogy of Fallot (TOF) has been per-formed for more than 4 decades, and a favorable
long-term outcome has been documented for most
patients.1-4 Approximately 5% of patients require reop-
eration after repair of TOF. Indications for reoperation
have included pulmonary regurgitation or stenosis,
residual right ventricular (RV) outflow tract obstruc-
tion, conduit degeneration, residual ventricular septal
defect, aortic valve regurgitation or stenosis, and tri-
cuspid regurgitation.1,3-8 As the number of long-term
survivors increases, the late complications of heart fail-
ure, arrhythmias, and sudden death have also increased.
Although many patients with severe pulmonary
regurgitation may be asymptomatic, a deleterious effect
on RV function and exercise capacity has been demon-
strated.9 This becomes more important when other
hemodynamically significant lesions such as distal pul-
monary artery stenosis or residual ventricular septal
defect are present. In addition, evidence suggests that
long-standing pulmonary regurgitation with right heart
enlargement may be associated with the development
of arrhythmias and sudden death.10-14 Previous studies
have shown that pulmonary valve replacement (PVR)
for symptomatic pulmonary regurgitation improves
functional status and RV function.6,15-20 The purpose of
this review was to examine our late results of PVR after
repair of TOF.
Patients and methods
Patient population. Between July 1, 1974, and January 1,
1998, 42 patients (16 female, 26 male) underwent PVR after
repair of TOF at our institution. Demographic data are shown
in Table I. Exclusion criteria included patients who had a
valved conduit placed from the right ventricle to the pul-
monary artery at the time of TOF repair and patients with
major associated congenital cardiac malformations such as
complete atrioventricular canal with TOF. The majority of
patients (76%) were in New York Heart Association (NYHA)
class III or IV preoperatively. Palliative operations that were
performed before TOF repair are shown in Table IIA, and
operations performed after TOF repair and before PVR are
shown in Table IIB. Management of the RV outflow tract
obstruction at the time of TOF repair is shown in Table III.
Evaluations of pulmonary and tricuspid regurgitation and
RV dysfunction and enlargement were subjectively classified
into mild, moderate, moderately severe, and severe.
Preoperative echocardiography (n = 36) demonstrated moder-
ately severe or severe pulmonary regurgitation in all patients,
moderately severe to severe tricuspid regurgitation in 38%,
moderately severe to severe reduction in RV function in 59%,
and moderate to severe RV enlargement in 69% of patients.
Preoperative cardiac catheterization was performed in 32
(76%) patients; hemodynamic data are shown in Table IV. A
major indication for operation in all patients was pulmonary
regurgitation. Other associated lesions were common and
included tricuspid regurgitation, residual ventricular septal
defect, and RV outflow tract or pulmonary artery obstruction.
Decreased exercise tolerance was present in 24 (58%)
patients, symptomatic right heart failure in 9 (21%), RV and
right atrial dilatation with associated supraventricular
arrhythmias in 5 (12%), progressive RV dilatation without
arrhythmias in 3 (7%), and intermittent ventricular tachycar-
dia in 1 (2%). In our practice, we have used the following cri-
teria to help select patients who would benefit from PVR
after TOF repair: (1) the presence or progression of symp-
toms (ie, decreased exercise tolerance and poor functional
class), (2) evidence of deteriorating RV function or signifi-
cant and progressive RV enlargement, (3) the development or
progression of atrial and/or ventricular arrhythmias, or (4) the
development/progression of tricuspid regurgitation. 
Follow-up. Clinical data were collected from the patients’
medical records. Each patient (or parent) and/or personal
physician was interviewed with a standardized telephone
questionnaire. 
Statistical analysis. Early (hospital) mortality was defined
as death within 30 days of operation or before hospital dis-
charge, whichever was longer. Clinical and demographic
variables were expressed as mean and standard deviation.
Continuous variables were analyzed with Wilcoxon rank-sum
tests. Comparisons of preoperative and postoperative echo
measurements and NYHA class were done by means of the
sign rank test. Survival and survivorship free of reoperation
were estimated by the Kaplan-Meier method.21 Survival
curves were compared with log-rank tests.22 The effect of
continuous variables on survival and the relationships of risk
factors to survival were evaluated with the Cox proportional-
hazards model.23
Results
All patients underwent standard surgical techniques
including repeat median sternotomy and cardiopul-
monary bypass. PVR and concomitant procedures
could be performed without aortic crossclamping in 20
(48%) patients. Aortic crossclamping was necessary in
22 (52%) patients, and a period of circulatory arrest
was required in 3 patients. PVR was performed with a
porcine heterograft prosthesis in 25 (60%) patients, a
pericardial heterograft prosthesis in 8 (19%), an aortic
homograft in 6 (14%), and a pulmonary homograft in 3
(7%). Isolated PVR was performed in 5 (12%) and
PVR with associated procedures was performed in 37
(88%) (Table V). The mean time interval between
index operation and PVR for isolated PVR (9.7 years)
versus PVR with a concomitant procedure (10.9 years)
was not significantly different (P = .8). The median
heterograft pulmonary valve size was 25 mm (range
17-31 mm) and the median homograft valve size was
23 mm (range 21-26 mm). Intraoperative prebypass
peak systolic RV pressure was 61.9 ± 28 mm Hg com-
pared with 49 ± 11 mm Hg after bypass (P = .624). The
346 Discigil et al The Journal of Thoracic and
Cardiovascular Surgery
February 2001
peak systolic right ventricular/left ventricular (RV/LV)
pressure ratio before and after bypass was 0.58 ± 0.17
and 0.46 ± 0.12, respectively (P = .01). 
Early mortality occurred in 1 (2%) patient. This
patient underwent repair of TOF at 5 years of age, and
PVR was performed at 19 years of age for poor exer-
cise tolerance, severe RV dilatation and dysfunction,
and right-sided heart failure with ascites and peripher-
al edema. In addition, he had severe tricuspid regurgi-
tation and stenoses of the superior vena cava and right
pulmonary vein. The LV ejection fraction was 30% to
35%. The operative procedure included PVR (hetero-
graft 23 mm), tricuspid valve replacement (heterograft
Table I. Demographic data of 42 patients undergoing late PVR after TOF repair
Mean ± SD Range
TOF repair (patient age) 11.2 ± 14.8 y 2.5 mo–61 y
PVR (n = 42) (patient age) 22 ± 16.4 y 1.8 y–65 y
Interval, repair to isolated PVR (n = 5) 9.7 ± 11.3 y 2.1 y–29.3 y
Interval, repair to PVR + other* (n = 37) 11.0 ± 9.4 y 1.3 mo–33.1 y
Re-PVR (n = 8) (patient age) 16.7 ± 8.1 y 5.5 mo–29.6 y
Interval, PVR to re-PVR 9.0 ± 4.2 y 3.8 y–16.8 y
PVR, Pulmonary valve replacement; TOF, tetralogy of Fallot.
*Other = concomitant procedure.
Table IIA. Palliative procedures performed in 28








TOF, Tetralogy of Fallot.
*Some patients had more than one palliative procedure. 
†Pulmonary valvotomy (n = 1), pulmonary valvectomy (n = 1), Brock
infundibulectomy (n = 1), and closed right ventricular outflow tract recon-
struction (n = 1).
Table IIB. Procedures performed in 5 patients after
TOF repair and before late PVR
Procedure No. %
VSD patch leak repair (Qp:Qs > 1.5) 3 7
PA aneurysm plication 1 2
Coronary artery bypass grafting 1 2
PA, Pulmonary artery; PVR, pulmonary valve replacement; Qp:Qs, pul-
monary/systemic flow ratio; VSD, ventricular septal defect.
Table III.  Management of the RV outflow tract
obstruction at the time of TOF repair*
Procedure No. %
Infundibular muscle resection† 38 90
Transannular patch† 29 69
Pulmonary valvotomy, no patch 9 21
Pulmonary valvectomy, no patch 2 5
RV, Right ventricular; TOF, tetralogy of Fallot.
*Some patients had more than one outflow tract procedure.
†With associated valvotomy or valvectomy.
Table IV. Cardiac catheterization data in 32 (76%)
patients before late PVR after TOF repair*
Variable Mean ± SD
PA systolic pressure (mm Hg) 53 ± 20 
PA diastolic pressure (mm Hg) 9.9 ± 6.9
Peak RV systolic pressure (mm Hg) 62.6 ± 19.8
Peak systolic RV/LV ratio 0.56 ± 0.18
LV, Left ventricular; PA, pulmonary artery; PVR, pulmonary valve replace-
ment; RV, right ventricular; TOF, tetralogy of Fallot.
*Twelve patients had leakage of a ventricular septal defect patch with a pul-
monary/systemic flow ratio of 1.5 or less.
Table V. Associated procedures performed in patients
undergoing PVR after TOF repair
No. of patients %
Associated procedures* 37 88
PA patch angioplasty 17 40
Tricuspid valve repair 16 38
RVOT patch enlargement 13 31
VSD patch leak repair 12 29
ASD closure 4 10
Repair RVOT aneurysm 3 7
Distal PA dilatation 3 7
Tricuspid valve replacement 2 5
CABG 2 5
Right-sided maze procedure 1 2
Aortic valve replacement 1 2
Potts anastomosis closure 1 2
ASD, Atrial septal defect; CABG, coronary artery bypass grafting; PA, pul-
monary artery; PVR, pulmonary valve replacement; RVOT, right ventricular
outflow tract; TOF, tetralogy of Fallot; VSD, ventricular septal defect.
*Some patients had more than one associated procedure.
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29 mm), and patch enlargement of the superior vena
cava and right-sided pulmonary veins. The postbypass
RV/LV pressure ratio was 0.7 and the gradient across
the pulmonary prosthesis was 5 mm Hg. His postoper-
ative course was complicated by multisystem organ
failure, and he died 40 days after the operation.
Morbidity included prolonged ventilatory support
(>48 hours) in 7 (17%) patients, sternal wound infec-
tion in 2 (5%), and stroke, lower extremity compart-
ment syndrome, exploration for bleeding, and partial
gastrectomy for gastrointestinal bleeding in 1 (2%)
patient each. The mean length of hospital stay was 14.5
days.
Follow-up. Follow-up was complete in all patients
and ranged up to 22.9 years. Total follow-up was 329.5
patient-years and the mean follow-up was 7.8 ± 6.0
years. There were 6 late deaths, 3 of which were known
to be cardiac related. Overall survival for all patients (n
= 42) was 95.1% ± 3.4% and 76.4% ± 8.9% at 5 and 10
years, respectively (Fig 1). The first late cardiac death
occurred in a 65-year-old woman who died of chronic
biventricular heart failure 8.2 years after PVR. She had
undergone PVR 7 weeks after complete repair of TOF
for poor exercise tolerance, progressive RV dilatation,
and right-sided heart failure. The second death
occurred in a 13-year-old boy with TOF and absent
pulmonary valve syndrome who died suddenly while
playing soccer 5 years after PVR, presumably of an
arrhythmia. At autopsy the right ventricle showed
marked dilatation. He had no known arrhythmias
Fig 1.  Overall survival for all patients (n = 42) undergoing PVR after TOF repair. Expected survival for an age-
and sex-matched population is also shown.
Fig 2. NYHA functional class before and at last follow-up in patients undergoing PVR after TOF repair.
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before PVR. The third cardiac death occurred in a 27-
year-old man with a history of ventricular tachycardia
before PVR; he died suddenly 8 months after PVR,
presumably of an arrhythmia. Marked RV dilatation
was found at autopsy. Because the number of late car-
diac deaths was small (n = 3), univariate analysis could
not demonstrate any significant risk factors for cardiac-
related late mortality. Specifically, preoperative NYHA
class, age at the time of PVR, the time interval between
TOF repair and PVR, intraoperative peak RV pressure,
and intraoperative peak RV/LV pressure ratio were not
found to be significant risk factors.
Late echocardiography performed at a mean of 8.2
years after the operation (range 8 months–17 years)
demonstrated persistent moderate to severe reduction
in RV function in 18% (vs 59% preoperatively, P =
.03), and moderate to severe RV enlargement was noted
in 44% (vs 69% preoperatively, P = .06). Mild or no
residual tricuspid regurgitation was noted in 90% of
patients. There were no residual atrial or ventricular
septal defects.
Among the 5 patients who had supraventricular
arrhythmias before PVR (including 1 patient with
chronic atrial fibrillation who underwent a right-sided
maze procedure), 1 patient had a recurrence of arrhyth-
mias 5 years after PVR. This patient ultimately under-
went placement of a permanent pacemaker for sinus
node dysfunction. She has been maintained in a paced
atrioventricular rhythm receiving amiodarone therapy
without recurrence of atrial fibrillation. The other 4 are
in normal sinus rhythm without antiarrhythmic agents.
One of the 5 patients also had frequent premature ven-
tricular beats and syncope before the operation; there
has been no reported recurrent syncopal event or sig-
nificant ventricular ectopy after PVR. Severe RV and
right atrial dilatation were present preoperatively in all
5 patients who had supraventricular arrhythmias; at late
follow-up, only mild to moderate RV dilatation was
present. The patient with chronic atrial fibrillation who
underwent a right-sided maze procedure is in sinus
rhythm at follow-up. NYHA functional class of
patients was improved significantly; preoperatively,
76% of patients were in NYHA class III-IV, and after
PVR, 97% of surviving patients were in NYHA class I-
II (P = .0001) (Fig 2).
Eight patients have subsequently required re-replace-
ment of the pulmonary valve (re-PVR) at a mean time
of 9.0 ± 4.2 years (range 3.8-16.8 years) after PVR.
There was no early mortality. All 8 patients who under-
went re-PVR had had a heterograft prosthesis (6
porcine, 2 pericardial) placed at the time of PVR; the
mean age at PVR was 7.7 years (range 1.8-18 years).
Prostheses used at the time of re-PVR were pulmonary
homograft in 4, aortic homograft in 2, and porcine het-
erograft in 2. Freedom from re-PVR was 93.1% ± 4.7%
and 69.8% ± 10.7% at 5 and 10 years, respectively (Fig
3). Preoperative NYHA class III or IV was not a risk
factor for re-PVR (P = .69). The only significant risk
factor for re-PVR by univariate analysis was young age
at the time of PVR (P = .023). 
Discussion
Numerous studies have demonstrated very good
long-term survival and good quality of life in the
Fig 3.  Freedom from re-PVR in patients who underwent PVR after TOF repair.
mias), evidence of deteriorating RV function, and
development and progression of tricuspid regurgita-
tion. In addition to PVR, it has been our policy to repair
concomitantly all additional anatomic lesions such as
atrial or ventricular septal defects, tricuspid regurgita-
tion, and surgically accessible proximal and distal pul-
monary artery stenoses, even if they are mild, to pro-
vide the best opportunity for recovery of RV function.
Although RV size decreased in most patients, this
reduction did not reach statistical significance (P =
.06), despite the finding of significant improvement in
RV function (P = .03). Since the majority of patients
had only mild or no residual tricuspid regurgitation
(90%) at late follow-up, persistent RV dilatation is
more likely due to chronic underlying changes in the
myocardium and thus would be less likely to regress
after PVR. Since the problems related to late arrhyth-
mias can be important and may be related to RV dilata-
tion, our practice over the years has been to advise
PVR earlier with the hope that irreversible anatomic
and pathologic changes in the myocardium would be
avoided.
Previous studies have demonstrated correlations
between supraventricular or ventricular arrhythmias
due to right-sided heart enlargement after TOF repair
and the occurrence of sudden death.10-14 Six patients in
this review had arrhythmias before PVR: 5 supraven-
tricular and 1 ventricular. Of the 3 known late cardiac
related deaths, 2 were due to presumed arrhythmias but
only 1 of the patients was known to have had an
arrhythmia (paroxysmal ventricular tachycardia)
before PVR. One of the 5 patients who had a preoper-
ative supraventricular arrhythmia was in chronic atrial
fibrillation; a right-sided maze procedure25 was per-
formed in conjunction with PVR, and sinus rhythm was
present after the operation. Although 3 patients who
had other types of supraventricular tachycardia were
also in normal sinus rhythm postoperatively as a result
of correction of their pulmonary regurgitation and
other anatomic defects, this favorable outcome cannot
be expected in all patients. Accordingly, for patients
having documented preoperative supraventricular
arrhythmias, we prefer to perform concomitant appro-
priate antiarrhythmia procedures (right-sided maze,
cryoablation, division of accessory conduction path-
ways) at the time of PVR. In addition, a right reduction
atrioplasty is also performed if right atrial enlargement
is marked. 
Two patients died suddenly during follow-up; one
was known to have paroxysmal ventricular tachycardia
preoperatively. Postmortem examination of the hearts
showed severe right atrial and RV dilatation in both.
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majority of patients after repair of TOF.1,2 As the num-
ber of long-term survivors after repair of TOF increas-
es, so does the number of late complications.
Pulmonary regurgitation after repair of TOF is com-
mon, especially in patients who require a transannular
patch reconstruction at the time of repair. Although pul-
monary regurgitation can be well tolerated for many
years, it eventually results in progressive RV dilatation,
dysfunction, and symptoms, necessitating PVR. Severe
pulmonary regurgitation in the presence of associated
lesions such as residual RV outflow tract obstruction or
residual ventricular septal defect is usually less well
tolerated and may necessitate reoperation even earlier.
Despite the causes for reoperation, the early mortality
has been low and the late survival and functional results
have generally been very good.6-8,15-17,19,20,24 The late
results of patients undergoing PVR after repair of TOF
in this review are consistent with those of previous
reports. 
Isolated PVR was performed in a minority of patients
(only 12%) in the present study. The expected longer
time interval between TOF repair and PVR for patients
with isolated pulmonary regurgitation as compared
with those with pulmonary regurgitation plus addition-
al hemodynamic problems was not present in this
series. This may be due to the small number of patients
undergoing isolated PVR or the relatively minor
degrees of the associated defects. These included mild
to moderate RV outflow tract or distal pulmonary artery
obstruction (preoperative peak RV/LV pressure ratio
was 0.58 ± 0.17) or small residual ventricular septal
defect (pulmonary/systemic flow rate < 1.5). 
Determining the appropriate time for PVR in patients
with significant pulmonary regurgitation can be diffi-
cult. Ideally, all important anatomic lesions should be
treated early to avoid deterioration of RV function and
development of associated problems. However, all bio-
prostheses have a limited life expectancy, and one
would like to avoid PVR until it is clearly indicated.
The only early death in this series occurred in a patient
who had a delayed referral for operation. On preopera-
tive evaluation, he had very limited exercise tolerance,
severe RV dilatation, severe tricuspid regurgitation,
right-sided heart failure with ascites and peripheral
edema, and severe depression of both RV and LV func-
tion. We believe surgery should be considered long
before such advanced clinical deterioration has
occurred. In our practice, current indications for PVR
after TOF repair have included the presence and pro-
gression of symptoms (decreased exercise tolerance
and poor functional class), the development/progres-
sion of arrhythmias (especially ventricular arrhyth-
Persisting RV dilatation and dysfunction are known to
be substrates for ventricular arrhythmias and sudden
death.10-14 Prevention of progressive RV dilatation and
dysfunction is a major reason for advising PVR, even
in the absence of symptoms. For patients with known
paroxysmal ventricular tachycardia, complex ventricu-
lar premature beats, or a history of syncope or sustained
palpitations, we usually perform a preoperative electro-
physiologic study. The primary reason for preoperative
study is to identify and locate the mechanism of any
inducible ventricular tachycardia to direct a surgical
approach for tachycardia ablation. Some ventricular
arrhythmias will not reappear after PVR and repair of
all other hemodynamic lesions, especially if a success-
ful surgical ablation can be performed. However, if
ventricular arrhythmias were present postoperatively,
especially in the presence of RV dilatation, an electro-
physiologic study would be repeated and strong con-
sideration given to prophylactic implantation of an
automatic internal cardioverter-defibrillator. 
Although the mean interval from TOF repair to PVR
was 9 years in this review, 1 patient who required
PVR soon after TOF repair requires special comment.
She had undergone an uneventful TOF repair with a
transannular patch at the age of 56 years. However,
she returned 6 weeks later with exercise intolerance
and a dilated right ventricle. A small residual ventric-
ular septal defect was also present. She underwent
PVR with closure of the ventricular septal defect (one
stitch) and subsequently improved considerably.
Although pulmonary regurgitation appears to be well
tolerated in children after TOF repair, we and others26
have observed that adults may tolerate pulmonary
regurgitation less well. Accordingly, we currently per-
form PVR in nearly all adult patients undergoing pri-
mary repair of TOF. 
The only risk for re-PVR in the 8 patients who
required reoperation was young age at the time of PVR.
Although no significant difference in valve durability
was detected between types of prostheses used (hetero-
graft vs homograft) in this small number of patients, we
presently do not favor cryopreserved homografts in
older children and adults because of their disappointing
late results.27
Our current preference is to place the largest porcine
bioprosthesis possible (in adults a size 27 or 29 mm) at
or just below (apical to) the pulmonary anulus. Room
for the prosthesis is created by a pericardial patch that
roofs and enlarges the RV outflow tract, pulmonary
anulus, and proximal main pulmonary artery.6,18,24 In
our experience, the durability of this type of recon-
struction is much better than that for cryopreserved
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homografts.18 We have performed this technique to
reconstruct the right ventricle–pulmonary artery con-
nection since 1983 in more than 80 adult patients with
congenital heart disease and have had no known reop-
erations for prosthetic valve failure. The overall con-
duct of repeat sternotomy for PVR or revision of the
right ventricle–pulmonary artery connection consists of
aortic and single right atrial cannulation with mild to
moderate hypothermia with no aortic occlusion in the
absence of residual septal defects. Bicaval cannulation
is performed when additional intracardiac repair is
required. Aortic occlusion is used for additional proce-
dures that would require cardioplegic arrest (eg, repair
of an atrial or ventricular septal defect or aortic valve
replacement). The decision to expose the femoral ves-
sels before the repeat sternotomy is determined by the
operating surgeon. The presence of a severely dilated
right atrium and right ventricle, in addition to the
absence of a radiolucent line on lateral chest x-ray film
between the posterior sternum and anterior heart, is
sometimes helpful in determining potentially high-risk
reopenings. A previously placed right ventricle–pul-
monary artery conduit that is directly posterior to the
sternum would also suggest potential problems with
sternal re-entry. Despite these findings, exposure of the
femoral vessels before repeat sternotomy is performed
in only a small percentage of patients. We prefer to use
the largest stented heterograft prosthesis possible and
to augment the roof of the RV outflow tract with peri-
cardium (usually glutaraldehyde-preserved bovine
pericardium) to maximize prosthetic valve size. In our
practice, the use of the homograft (aortic or pulmonary)
to reconstruct the right ventricle is reserved for infants,
small children, and patients undergoing the Ross pro-
cedure. Although the use of mechanical prostheses in
the pulmonary position has been described in the liter-
ature,28,29 we have generally avoided their use because
of the low right-sided pressures, potential thrombosis
problems, and the need for long-term anticoagulation.
Intraoperative RV and pulmonary arterial pressures are
measured before and after PVR, and intraoperative
transesophageal echocardiogram is used routinely. 
Limitations of this study include the lack of postop-
erative catheterization data to quantitate improvement
in hemodynamics and lack of exercise testing before
and after surgery to assess improvement in cardiopul-
monary function. However, significant subjective
improvement in functional class was observed in
almost all patients, as judged by the patients as well as
their physicians. Others have been able to show signif-
icant objective improvement in cardiorespiratory
parameters after PVR.15,17,30 Reduction of heart size on
interaction in tetralogy of Fallot: QRS prolongation relates to
right ventricular size and predicts malignant ventricular arrhyth-
mias and sudden death. Circulation 1995;92:231-7.
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chest radiographs late after PVR was dramatic in some
patients, but a more definitive assessment of improve-
ment would have been provided by serial measure-
ments of cardiothoracic ratios. Severity of RV dysfunc-
tion and enlargement was assessed subjectively and
noted retrospectively from clinical echocardiography
and cardiac catheterization reports. More recent tech-
niques for echocardiographic assessment of ventricular
function would have provided more precise data for
preoperative and postoperative comparisons.
In summary, late PVR after TOF repair significantly
improves RV function, functional class, and atrial
arrhythmias. PVR can be performed with low mortali-
ty. Subsequent re-PVR may be necessary to maintain
functional improvement. 
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